NDC 69097-974

Meprobamate

Meprobamate

Meprobamate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Meprobamate.

Product ID69097-974_1fe09b66-c58f-4d50-8932-96f52bda4bcb
NDC69097-974
Product TypeHuman Prescription Drug
Proprietary NameMeprobamate
Generic NameMeprobamate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-06-07
Marketing CategoryANDA /
Application NumberANDA040797
Labeler NameCipla USA Inc.
Substance NameMEPROBAMATE
Active Ingredient Strength200 mg/1
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 69097-974-07

100 TABLET in 1 BOTTLE (69097-974-07)
Marketing Start Date2021-06-07
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Meprobamate" or generic name "Meprobamate"

NDCBrand NameGeneric Name
46708-019MEPROBAMATEMEPROBAMATE
46708-020MEPROBAMATEMEPROBAMATE
51672-4147MeprobamateMeprobamate
51672-4148MeprobamateMeprobamate
52549-4147MeprobamateMeprobamate
52549-4148MeprobamateMeprobamate
55111-640MeprobamateMeprobamate
55111-641MeprobamateMeprobamate
62332-019MeprobamateMeprobamate
62332-020MeprobamateMeprobamate
69097-974MeprobamateMeprobamate
69097-975MeprobamateMeprobamate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.